| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8722817 | HPB | 2018 | 6 Pages |
Abstract
In this study of selected patients who underwent IgG4 testing, 9% of elevated IgG4 patients had PDAC. The overreliance on IgG4 as diagnostic for AIP may lead to mis-diagnosis and delayed treatment for PDAC.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Linda M. Pak, Mark A. Schattner, Vinod Balachandran, Michael I. D'Angelica, Ronald P. DeMatteo, T. Peter Kingham, William R. Jarnagin, Peter J. Allen,